Zymeworks (ZYME) Cash from Financing Activities: 2021-2023

Historic Cash from Financing Activities for Zymeworks (ZYME) over the last 2 years, with Dec 2023 value amounting to $50.6 million.

  • Zymeworks' Cash from Financing Activities rose 13524.67% to $50.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $81.8 million, marking a year-over-year decrease of 24.62%. This contributed to the annual value of -$20.5 million for FY2024, which is 124.99% down from last year.
  • Latest data reveals that Zymeworks reported Cash from Financing Activities of $50.6 million as of Q4 2023, which was up 2,569.36% from $1.9 million recorded in Q3 2023.
  • In the past 5 years, Zymeworks' Cash from Financing Activities ranged from a high of $108.6 million in Q1 2022 and a low of -$377,000 during Q4 2022.
  • In the last 3 years, Zymeworks' Cash from Financing Activities had a median value of $1.7 million in 2023 and averaged $21.2 million.
  • In the last 5 years, Zymeworks' Cash from Financing Activities crashed by 154.72% in 2022 and then skyrocketed by 13,524.67% in 2023.
  • Zymeworks' Cash from Financing Activities (Quarterly) stood at $689,000 in 2021, then crashed by 154.72% to -$377,000 in 2022, then skyrocketed by 13,524.67% to $50.6 million in 2023.
  • Its Cash from Financing Activities stands at $50.6 million for Q4 2023, versus $1.9 million for Q3 2023 and $27.6 million for Q2 2023.